Market Dynamics
I will be moderating a panel, Venture Capitalists’ Best Practices on Commercializing Innovation at the Molecular Diagnostics World Congress on September 29, 2011 at the South San Francisco Conference Center. Here’s the panel topic summary, hope to see you there. Successful venture capital investing in molecular diagnostics requires proper commercialization of innovation. But how does this innovation get […]
Read MoreJuly 1, 2011 source: Genetic Engineering & Biotechnology News by Brad Webb Rapid Transition from Laboratory Discoveries to Commercialization Is Transforming Healthcare It’s been less than a decade since a full human genome was sequenced, but already there is talk that the promise of genomics-inspired personal medicine is not being realized. I couldn’t disagree more. […]
Read More
April 21, 2011 source: Gigaom When it comes to clean-energy investing 2.0, venture capitalists are beyond looking for the silver bullet — or the magic battery –- they spent the last decade hunting and hoping for. Today, VCs are more likely to invest their dollars in slightly less ambitious energy-efficiency projects, Paul Kedrosky, senior fellow […]
Read MoreMarch 21, 2011 source: NVCAccess — Emily Mendell interviewed Claremont Creek Ventures’ Micah Myers – Today’s Monday meeting is with Micah Myers of Claremont Creek Ventures. Micah joined Claremont Creek Ventures in 2009. Prior to joining Claremont Creek Ventures, Micah worked as an Analyst with the energy team at Passport Capital where he focused on […]
Read MoreMarch 16, 2011 source: VentureBeat GreenBeat — “It’s a huge tragedy, but it’s only gonna give a tailwind to alternative energy technologies,” Myers said. “There will be more of a willingness to put capital to work in solar and wind.” — An escalating crisis at nuclear power plants in Japan following a massive earthquake and […]
Read MoreMarch 8, 2011 source: GreentechEnterprise – “When you are looking at waste heat, there is an interest if there is a very fast payback of less than two years when you are thinking of the stationary-furnace-type industries” said Paul Straub – Activity has been perking up in a once-obscure area. Here’s the report from ARPA-E. […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.